Zhejiang Tiantai Pharmaceutical Co., Ltd. (listed), founded in June 1998, is specialized in R&D, manufacturing and sales of antifungal and antibiotics series featured APIs products including Clindamycin Hydrochloride, Clindamycin Phosphate and Amphotericin B, and the CRO&CDMO business of APIs. The company is one of the major manufacturers of Clindamycin Hydrochloride and Clindamycin Phosphate at home and abroad.
Focusing on the big health industry, the company has built the traditional featured APIs and API CDMO&CRO business plate and synthetic biology drugs plate. Relying on the advantages of existing products, technologies, teams and platforms, the company become a low-cost, scaled, APIs-and-preparations integrated manufacturing base of featured generic drugs, and gradually developed towards the innovative drugs.
TiantaiPharm (Headquarter): National high-tech enterprise, a featured API manufacturing base, located in TiantaiCounty, Taizhou City. The registered capital is 77.4 million Yuan and the total number of employees is nearly 400.
Hangzhou Lead Biotech Co., Ltd. ( Full-invested Subsidiary): National high-tech enterprise, engaged in CDMO of featured APIs and advanced intermediates. Dedicate to the development and application of new reaction technologies (unnatural optical amino acids synthesis, di-fluorination, cascade reaction+continuous operation) and synthetic biology.Nearly 120 R&D employees.
Hangzhou Tianze Biopharmaceutical Co., Ltd. ( Full-invested Subsidiary): Platform of liposome preparations manufacturing and advanced drug products development. Nearly 30 R&D employees.
Email：md@m.7668888.cn
Web：m.7668888.cn
Int'l Trade Depart：0086-576-83993127
Domestic Trade Depart：0576-83993758
?2022 四川天臺藥業股有限我司我司 出版權任何
｜ ｜ ?